| 0.445 Delayed Data As of Nov 16 |  -0.0029 / -0.65%Today’s Change | 0.38 Today|||52-Week Range 0.83 | -32.70% Year-to-Date |
| Protalix (PLX) Reports Q3 Loss, Lags Revenue Estimates Nov 07 / Zacks.com - Paid Partner Content |
| Previous close | 0.45 |
| Today’s open | 0.47 |
| Day’s range | 0.43 - 0.47 |
| Volume | 159,163 |
| Average volume (3 months) | 769,344 |
| Market cap | $66.5M |
| Earnings growth (last year) | -124.45% |
| Earnings growth (this year) | +36.11% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +109.17% |
| P/E ratio | NM |
| Price/Sales | 4.50 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| VTGNVistaGen Therapeutic... | -0.06 | -3.24% |
| ONSOncobiologics Inc | +0.02 | +2.83% |
| LPTXLeap Therapeutics In... | +0.30 | +8.57% |
| KMPHKemPharm Inc | +0.19 | +8.09% |
| Next reporting date | March 14, 2019 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $19.2M |
| Annual profit (last year) | -$85.3M |
| Net profit margin | -443.18% |
Sector Health Services |
Industry Services to the Health Industry |
President, Chief Executive Officer & Director Moshe Manor |
Senior Vice President- Operations Yaron Naos |
Corporate headquarters Carmiel, Hazafon |
